---
$id: https://graph.org.ai/products/commodity/51182417
$type: Product
source: UNSPSC
code: "51182417"
title: "Risedronate sodium or risedronic acid"
class: "51182400"
classTitle: "Calcium regulators and calcium salts"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Risedronate sodium or risedronic acid

**UNSPSC Code**: 51182417
**Class**: [Calcium regulators and calcium salts](Calcium regulators and calcium salts.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a bone resorption inhibitor and biphosphonate with the molecular formula C7H11NO7P2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KM2Z91756Z, chemically known as phosphonic acid, (1-hydroxy-2-(3-pyridinyl)ethylidene)bis- but generally known as risedronic acid, which bears US NIH Compound Identifier 5245. European Medicines Agency schedules Risedronic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10330MIG. The term RISEDRONIC ACID is an International Non-Proprietary Name. World Health Organization schedules risedronic acid in its Anatomical Therapeutic Chemical (ATC) Classification. Risedronate sodium or risedronic acid bears US NLM identifiers UMLS ID C0140610 and NCI Concept Code C66517. SMILES: P(=O)(O)(O)C(P(=O)(O)O)(O)CC1CCCNC1.

